NMRA · Neumora Therapeutics, Inc.
$1.60
-0.13 (-7.51%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the current available cash and cash equivalents will not be sufficient to fund the Company’s operating plans for at least twelve months from the issuance date of these condensed consolidated financial statements. Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$300.63M
Shares
187.90M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
7,563,131
-0.8% vs reported
Short Squeeze Score
69/100
Short interest 4.1% of shares — P68
Days to cover 11.0 — P91
Price vs VWAP +4.5% — P65
Short-volume trend +0.4% — P53
Short interest change -2.1% — P47
Worst FTD 0.16% of shares — P82
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 7,622,548 | 7,786,397 | -163,849 | 11.01 |
| 2026-07-15 | 7,786,397 | 6,682,749 | +1,103,648 | 7.56 |
| 2026-06-30 | 6,682,749 | 4,917,298 | +1,765,451 | 1.11 |
| 2026-06-15 | 4,917,298 | 5,581,263 | -663,965 | 2.17 |
| 2026-05-29 | 5,581,263 | 4,897,401 | +683,862 | 5.03 |
| 2026-05-15 | 4,897,401 | 4,601,847 | +295,554 | 2.97 |
| 2026-04-30 | 4,601,847 | 4,469,003 | +132,844 | 3.43 |
| 2026-04-15 | 4,469,003 | 4,326,409 | +142,594 | 3.50 |
| 2026-03-31 | 4,326,409 | 4,958,521 | -632,112 | 4.03 |
| 2026-03-13 | 4,958,521 | 5,216,610 | -258,089 | 4.91 |
| 2026-02-27 | 5,216,610 | 6,045,735 | -829,125 | 5.99 |
| 2026-02-13 | 6,045,735 | 5,634,962 | +410,773 | 2.57 |
| 2026-01-30 | 5,634,962 | 5,986,621 | -351,659 | 6.36 |
| 2026-01-15 | 5,986,621 | 7,502,647 | -1,516,026 | 1.55 |
| 2025-12-31 | 7,502,647 | 6,982,708 | +519,939 | 8.35 |
| 2025-12-15 | 6,982,708 | 6,468,823 | +513,885 | 7.16 |
| 2025-11-28 | 6,468,823 | 6,095,137 | +373,686 | 6.67 |
| 2025-11-14 | 6,095,137 | 6,542,312 | -447,175 | 4.05 |
| 2025-10-31 | 6,542,312 | 6,788,203 | -245,891 | 1.42 |
| 2025-10-15 | 6,788,203 | 6,775,172 | +13,031 | 11.90 |
| 2025-09-30 | 6,775,172 | 6,417,308 | +357,864 | 13.66 |
| 2025-09-15 | 6,417,308 | 5,233,308 | +1,184,000 | 16.97 |
| 2025-08-29 | 5,233,308 | 5,276,271 | -42,963 | 14.38 |
Showing 1–23 of 23 settlements
Key facts
CIK
1885522
CUSIP
640979100
13F (30d)
114 filings
112 filers
Visit website
Investor relations